Guizhou Xinbang Pharmaceutical Co. Ltd. | Ownership
Companies that own Guizhou Xinbang Pharmaceutical Co. Ltd.
China Universal Asset Management Co., Ltd.
46,678,739
4.65%
-45,769,410
0.33%
09/30/2017
E Fund Management Co., Ltd.
7,902,229
0.79%
-11,997,771
0.05%
09/30/2017
China Southern Asset Management Co., Ltd.
3,781,171
0.38%
-1,014,514
0.03%
12/31/2017
Bank of Communications Schroder Fund Management Co., Ltd.
2,576,050
0.26%
2,575,285
0.06%
12/31/2017
Guotai Asset Management Co., Ltd.
2,160,150
0.22%
-1,843,734
0.03%
12/31/2017
The Vanguard Group, Inc.
1,840,931
0.18%
0
0%
07/31/2018
Guotai Junan Allianz Fund Management Co., Ltd.
1,836,015
0.18%
91,900
0.1%
12/31/2017
Fullgoal Fund Management Co., Ltd.
1,658,514
0.17%
1,658,514
0.01%
12/31/2017
ICBC Credit Suisse Asset Management Co., Ltd.
1,553,311
0.16%
-1,491,689
0.02%
12/31/2017
UBS SDIC Fund Management Co., Ltd.
1,500,000
0.15%
1,484,301
0.1%
12/31/2017
| Address |
6/F, Garden No. 1, Kekai
Guiyang Guizhou 550018
China
|
|
Employees
|
- |
| Website |
http://www.xinbang.com |
| Updated |
07/08/2019 |
| Guizhou Xinbang Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its business segments include pharmaceutical production and development, medical services, and medicine distribution sectors. Its products include medicines for cardiovascular and cerebrovascular, digestive system, endocrine, blood system, and urinary system diseases. |
